Molecular Response After Concurrent Exercise With Low Glycogen
Glyconcurrent
The Effects of Glycogen Availability on the Skeletal Muscle Molecular Response After Concurrent Exercise
1 other identifier
interventional
14
1 country
1
Brief Summary
This is a randomized, counterbalanced crossover design, in which 14 male subjects will complete two experimental trials. Each trial will be separated by a minimum of at least 12 days (range: 12-30 days). The study aims to investigate the effects of low glycogen availability on skeletal muscle molecular response after a concurrent exercise day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 26, 2016
CompletedFirst Posted
Study publicly available on registry
January 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedOctober 3, 2018
February 1, 2016
3 months
January 26, 2016
October 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proteins involved in hypertrophy
10 hours
Study Arms (2)
Low carbohydrate
EXPERIMENTALSubjects will eat a low carbohydrate diet
High carbohydrate
EXPERIMENTALSubjects will eat a high carbohydrate diet
Interventions
Eligibility Criteria
You may qualify if:
- Male gender between 18 and 30 years of age
- BMI between 18.5 - 25 kg/m2
- Participating in regular exercise training (at least 1 exercise session, and a maximum of 3 exercise session per week)
- Used to different types of exercise (endurance, resistance and/or concurrent)
- Willing to give blood samples
- Willing to give muscle biopsies
- No use of antibiotics during the study or in the past month
- No drug use
- Suitable veins for blood withdrawal
- Registered by a general-practitioner
- Consumption of alcohol beverages is less than 21 per week
- No blood donor during the study
- No vegetarian and willing to eat meat during the experimental days
- Able to be present and participate at both test days and pre testing moments
- Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University
- +3 more criteria
You may not qualify if:
- Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, gluten intolerance)
- Systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>100 mmHg
- Use of medications known to interfere with gene expression in the muscles (i.e. statins, fenofibrate)
- Use of antithrombotic therapy (marcoumar, sintromitis).
- Diagnosed diabetes mellitus type 1 or 2
- (Chronic) injuries of the locomotor system that can interfere with the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Human Nutrition, Wageningen University
Wageningen, Gelderland, 6703 HA, Netherlands
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2016
First Posted
January 29, 2016
Study Start
November 1, 2015
Primary Completion
February 1, 2016
Study Completion
April 1, 2016
Last Updated
October 3, 2018
Record last verified: 2016-02